-
1
Bismuth-containing drugs in clinical practice in the XXI century - history or a new round of possibilities?
Published 2024-09-01Subjects: Get full text
Article -
2
Comparison of the Eradication Rate between 1- and 2-Week Bismuth-Containing Quadruple Rescue Therapies for Helicobacter pylori Eradication
Published 2012-10-01Subjects: Get full text
Article -
3
A 10- or 14-day Bismuth-containing Quadruple Therapy as a First-line Helicobacter pylori Eradication Therapy: A Systematic Review and Meta-analysis
Published 2021-03-01Subjects: Get full text
Article -
4
-
5
IRRITABLE BOWEL SYNDROME AND ITS RELATIONSHIP WITH INTESTINAL MICROFLORA
Published 2017-12-01Subjects: Get full text
Article -
6
Estimation of cytoprotective effect of bismuth tripotassium dicitrate on gastric mucosa at <i>H. pylori</i> eradication and long-term drug intake
Published 2014-12-01Subjects: Get full text
Article -
7
The Role of the Pathoanatomical Diagnosis «Chronic Gastritis» in the System of Personified Cancer Prevention
Published 2018-09-01Subjects: Get full text
Article -
8
In Vitro Susceptibility and Synergistic Effect of Bismuth Against <i>Helicobacter pylori</i>
Published 2024-10-01Subjects: Get full text
Article -
9
Pharmacoeconomic evaluation of treatment in patients with Helicobacter pylori-associated diseases
Published 2014-08-01Subjects: Get full text
Article -
10
Modern potential of bismuth in gastroenterology
Published 2010-06-01Subjects: “…bismuthate tripotassium dicitrate…”
Get full text
Article -
11
The effectiveness of H. pylori therapy in patients with helicobacter pylori related functional dyspepsia
Published 2014-12-01Subjects: Get full text
Article -
12
Possibilities for optimization of eradication therapy for Helicobacter pylori infection in modern clinical practice
Published 2017-02-01Subjects: Get full text
Article -
13
Autoimmune chronic gastritis - a nosological entity or a syndrome?
Published 2015-12-01Subjects: Get full text
Article